{"paper_id":"1fa10d9b-d779-4775-b23d-86dadab3a7df","body_text":"Page 1/11\nKallistatin in Follicular Fluid of Women with\nEndometriosis and Its Correlation with IVF Outcome\nYuling Mao \nThird Aliated Hospital of Guangzhou Medical College https://orcid.org/0000-0002-9931-6579\nShaoquan Zhan \nThird Aliated Hospital of Guangzhou Medical College\nJingda Qiao \nInstitute of Neuroscience and Department of Neurology of the Second Aliated Hospital of Guangzhou\nMedical University\nLei Li \nThird Aliated Hospital of Guangzhou Medical College\nHanyan Liu \nThird Aliated Hospital of Guangzhou Medical College\nRui Chen  (  ruich@126.com )\nThird Aliated Hospital of Guangzhou Medical College\nResearch\nKeywords: Endometriosis; Kallistatin; follicular uid; IVF outcome\nPosted Date: January 9th, 2021\nDOI: https://doi.org/10.21203/rs.3.rs-140378/v1\nLicense:   This work is licensed under a Creative Commons Attribution 4.0 International License.  \nRead Full License\nVersion of Record: A version of this preprint was published at Gynecological Endocrinology on July 8th,\n2021. See the published version at https://doi.org/10.1080/09513590.2021.1928067.\n\nPage 2/11\nAbstract\nBackground: Endometriosis (EM) affects 10% of women in reproductive age and alters fertility. Its\nmanagement is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an\nendogenous protein that regulates differential signaling pathways and biological functions. However, the\nfunction and the underlying molecular mechanism in endometriosis and its correlation with IVF outcome\nhave not been determined. The purpose of this study was to evaluate KS concentrations in follicular uid\nof women with EM and controls women without EM who underwent IVF with embryo transfer (IVF–ET).\nMethods: Follicular uid KS concentrations from 40 patients with EM and 40 non-EM patients were\nmeasured by ELISA.\nResults: Compared with the non-EM patients, patients with EM had lower KS levels in follicular uid\n(281.67±104.60 pg/ml vs. 490.70 ±216.33pg/ml). The rates of fertilization(61.64±22.42% vs.\n71.00±24.39%) , available embryo (45.96±19.83% vs.50.61±26.26%)  and top-quality\nembryo(12.71±21.01% vs.16.04±16.87%) were signicantly lower in the EM group than in the control\ngroup. The KS concentrations in the follicular uid of women who conceived consequent to the treatment\nwere signicantly higher than those from women who did not in the combined EM and control groups.\nConclusions:\nThe present results indicate that the KS concentration in follicular uid could be used as a predictor for\nIVF–ET outcomes. This may contribute to the pathologic mechanism responsible for the poor outcome of\nIVF in patients with EM.\nBackground\nEndometriosis is a common chronic gynecologic disorder dened by the ectopic occurrence of\nendometrium-like tissue which is associated with pelvic pain and infertility[1]. It has been estimated at\n10% in women of reproductive age[2]. The causes of infertility in women with endometriosis may range\nfrom anatomical distortions due to adhesions and brosis to abnormalities and immunological\ndisturbances[3, 4]. Approximately 25–50% of infertile women have EM, and 30–50% of women with EM\nare infertile[5]. Assisted reproductive technology (ART) may be required with endometriosis-related\ninfertility. Accumulating evidence suggests that EM affects oocyte and embryo development as well as\nendometrial receptivity, resulting in poor in vitro fertilization (IVF) outcomes[6-10]. However, the\nmechanism is unclear.\n Follicular fuid (FF) provides an environment that controls oocyte growth and maturation, and plays a key\nrole in ovulation, subsequent fertilization and early embryo development[11]. Both cellular and secreted\nmediators are aberrantly expressed in the peritoneal fuid (PF) and plasma of EM patients[12]. Some\nstudies have shown that angiogenesis and tissue growth factor are increased in the serum and PF of\nwomen with EM[13, 14].\n\nPage 3/11\nFor these reasons, we analyzed the concentrations of KS in the FF of women undergoing IVF to identify\nfactors related to EM and to further elucidate its correlation with IVF outcome. KS is an endogenous\nprotein that regulates differential signaling pathways and biological functions inhibiting inammation,\nangiogenesis, oxidative stress, apoptosis, tumor growth and metastasis in animal models and cultured\ncells[15-22]. Plasma levels of KS are reduced in patients with sepsis, liver disease and obesity[23, 24]. Our\npreliminary data showed that KS in EM patients’ endometrial tissue and blood were much lower than\ncontrol patients without endometriosis and the decrease of KS is correlated with the severity of\nendometriosis. However, the concentrations of KS in the follicular uid of EM patients and its correlation\nwith IVF outcome have not been determined.\nThe aim of this study was to investigate KS in follicular uid of women with endometriosis and its\ncorrelation with IVF outcome. This information may form the basis of strategies to control these factors\nand improve the IVF outcomes in patients with EM.\nMethods\nSubjects\nA total of 80 patients who underwent IVF-ET between July 2017 and August 2018 in the Center for\nReproductive Medicine, Third Aliated Hospital of Guangzhou Medical University, were recruited for this\nstudy. The study population consisted of Forty women with EM and 40 women without EM. The presence\nor absence of endometriosis was con ﬁ rmed by laparoscopic surgery and post-operative histological\nexamination. Women with polycystic ovary syndrome, diabetes, hypertension, dyslipidemia, HIV infection\nor any active infection and autoimmune diseases were excluded. Follicular uid (FF) was extracted from\nboth groups.\nART procedures\nWomen were monitored and managed according to the hospital’s clinical protocols. Various controlled\novarian stimulation (COS) protocols were used, with 150-450 IU/day of recombinant FSH or human\nmenopausal gonadotropin in a gonadotropin-releasing hormone antagonist protocol, a long agonist\nprotocol, or a short agonist protocol. The protocols were determined according to each patient's\ncharacteristics (age, body mass index (BMI), AFC and AMH). Transvaginal oocyte retrieval was scheduled\n35-36 h after hCG injection ART was performed per standard operating procedure of the hospital.\nFertilization was assessed by the appearance of two pronuclei. Cleavage stage embryos were graded as\nper the Istanbul consensus. Fresh embryo transfer (ET) was performed 2-3 or 5 days later. Embryos were\nvitried frozen on day 3,5 or 6. The luteal phase was supported by vaginal administration of micronized\nprogesterone (400 mg/d) started on the day of ovarian puncture.\nFollicular uid collection\n\nPage 4/11\nFollicular uid was preserved at oocyte retrieval, by collecting the liquid aspirated from the follicle into the\nsuction tube, to avoid contamination by blood. Follicular uid samples from each follicle were pooled for\neach patient for measurement of KS concentrations. Pooled follicular uid was centrifuged at 1500g for\n10 min to eliminate cells and cell debris. And the supernatants were then stored at -20°C for KS\nconcentration measurements.\nKS and hormone assays\nThe follicular uid KS concentrations were collected and determined measured by enzyme-linked\nimmunosorbent assay (human kallistatin ELISA kits, Catalog Number: DY1669; R&D Systems, USA)\naccording to the manufacturer's protocol. The concentrations of serum oestradiol, FSH, LH, progesterone,\ntestosterone and AMH, and follicular uid oestradiol and progesterone, were measured by\nchemiluminescence (Roche, Switzerland).\nOutcome measure\nThe reproductive outcome of this study included implantation, clinical pregnancy, live birth rate (LBR) and\nspontaneous miscarriage rates. Neonatal outcomes included preterm birth, stillbirth, birth weight, low\nbirth weight and congenital anomalies. Live birth was dened as the delivery of any viable neonate who\nwas 28 weeks of gestation or older, and twins delivered by one mother were calculated as one live birth.\nClinical pregnancy was dened as the present of gestational sac on ultrasound at 6-8 weeks of gestation;\nlow birth weight was dened as the birth weight less than 2500 g and very low birth weight less than\n1500 g.\nStatistical analysis\nThe statistical analysis was performed using the Statistical Package for Social Science (SPSS) version\n22.0. The baseline characteristic was expressed as the mean ± SD (standard deviation) and differences\nin variables were compared by means of Student’s t-test. Categorical variables were described as\nfrequencies and percentages, and compared using chi-square test. A P-value of 0.05 was considered\nsignicant.\nResults\nPatient characteristics\n Eighty women were selected. Baseline characteristics of these women are shown in Table 1. No\nsignicant differences were observed between the EM and control groups regarding age, body mass\nindex and duration of sterility. In the control group, there were 4 patients with infertility due to tubal factor\n(10%), two cases of ovulatory dysfunction (5%), 20 cases of male factor (50%), 14 cases of unexplained\n(35%).30 patients in the control group were given IVF protocols, while 10 underwent ICSI procedures. In\nEM group, IVF protocols were given to 70% women and 30% underwent ICSI procedures.\n\nPage 5/11\nKS expression was decreased in FF of EM patients\nSerum concentration of base LH, FSH, Progesterone(P), Testosterone(T), E2 and AMH showed no\ndifference between the EM and control groups. Moreover, The FF KS concentrations in the EM patients\nwere 281.67±104.60 pg/ml and lower than those in the control group (490.70 ±216.33pg/ml) (P < 0.05)\n(Table 2).\nART Cycle Characteristics in EM and control subjects.\nComparisons of ART Cycle Characteristics between the EM and control groups were summarized in Table\n3. The AFC, Dosage of Gn, Endometrial thickness, No. of embryos retrieved, the rates of cleavage and No.\nof embryos transferred were similar among between the two FET groups. Meanwhile, the rates of\nfertilization, available embryo and top-quality embryo were signicantly lower in the EM group than in the\ncontrol group.\nKS concentrations in follicular uid from subjects with different pregnancy outcomes\nThe clinical pregnancy rate in the EM group was 61.54% (24/39), which was signicantly lower than that\nin the control group (67.57%, 25/37). In both the EM (Figure 1B) and control groups (Figure 1A), the KS\nconcentrations in the follicular uid of women who conceived consequent to the treatment were\nsignicantly higher than those in women who did not. The KS concentrations in the follicular uid of\nwomen who conceived consequent to the treatment were signicantly higher than those from women\nwho did not in the combined EM and control groups (P < 0.05; Figure 1C). To evaluate the potential of KS\nconcentrations in the follicular uid for predicting clinical pregnancy, receiver operating characteristic\n(ROC) curves were plotted, and the area under the curve (AUC) values were determined with the highest\nspecicity and sensitivity set as the optimal prediction point (Figure 1D). Optimal prediction point,\nsensitivities, specicities and AUC values were 292.78 pg/ml, 71.7%, 65% and 0.7279, respectively. The\npresent results indicate that the KS concentration in follicular uid could be used as a predictor for IVF–\nET outcomes.\nDiscussion\nFF composition is complex and is basically derived from plasma exudation and ovarian secretion[25]. It\nis an important environment for oocyte survival and directly affects oocyte maturation and quality. FF\ncontains a large number of cytokines, a variety of hormones, oxidation/ antioxidant systems and\nmetabolic products [13].\nIn this study, analysis of the levels of KS in follicular uid of women with EM and controls women without\nEM who underwent IVF with embryo transfer (IVF–ET). Data clearly show thatcompared with the non-EM\npatients, patients with EM had lower KS levels in follicular uid. This indicates that low KS concentrations\nin follicular uid may play a key role in folliculogenesis and the pathogenesis of EM. However, there were\nno differences in the concentrations of LH  FSH  P  T  E2 and AMH between the EM and control groups.\n\nPage 6/11\nThis means that the KS changes of follicular microenvironment caused by EM are independent of these\nsix factors.\nKS is an endogenous protein that regulates differential signaling pathways and biological functions. Our\npreliminary data showed that KS in EM patients’ endometrial tissue and blood were much lower than\ncontrol patients without endometriosis and the decrease of KS is correlated with the severity of\nendometriosis. However, the concentrations of KS in the follicular uid of EM patients and its correlation\nwith IVF outcome have not been determined. This study found that the rates of fertilization, available\nembryo and top-quality embryo were signicantly lower in the EM group than in the control group. This\nresult is consistent with the worse prognosis of EM reported in previous literature. We supposed that KS\ncan signicantly improve the quality of oocytes and embryos.\nHowever, whether KS can act as a biomarker for predicting the clinical pregnancy of EM remain unknown.\nROC curves were plotted in our study, result showed that the area under the curve (AUC) values was\n0.7279. The present results indicate that the KS concentration in follicular uid could be used as a\npredictor for IVF–ET outcomes.\nBased on the ndings of our study, we conclude that KS is associated with the microenvironment of FF in\npatients with EM. The change in the regulation network in EM inuence oocyte development, resulting in\npoor IVF outcomes. However, the results in this study should be validated in a large sample in the future.\nConclusion\nOur study provides a theoretical basis for the development of strategies to improve the outcome of IVF in\npatients with EM. This evidence may help to clarify the pathology of EM and seek new treatments for EM\npatients.\nAbbreviations\nEndometriosis                        EM\nKallistatin                           KS\nin vitro fertilization               IVF\nperitoneal fuid                   PF\nFollicular fuid                   FF\ncontrolled ovarian stimulation      COS\nbody mass index                 BMI\nlive birth rate                    LBR\n\nPage 7/11\narea under the curve              AUC\nluteinizing hormone               LH\nFollicle-Stimulating Hormone       FSH\nprogesterone                     P\ntestosterone                      T\nestrogen                        E2\nAnti-mullerian hormone           AMH\n \nDeclarations\nEthical Approval and Consent to participate\nThis study was approved by the ethics committee of the Third Aliated Hospital of Guangzhou Medical\nUniversity.\nConsent for publication\nNot applicable.\nAvailability of supporting data\nThe data sets used and/or analyzed during the current study are available from the corresponding author\non reasonable request.\nCompeting interests\nThe authors have declared that no conict of interest exists.\nFunding\nThis study was supported by National Nature Science Foundation of China, Grant Numbers: 81871211\nAuthors' contributions\nAll authors have contributed signicantly to this manuscript and each author has contributed to the\nmanuscript as follows: Yuling Mao and Rui Chen designed the project. Yuling Mao, Shaoquan Zhan\ncollected clinical samples and performed the ELISA experiments. Jingda Qiao and Lei Li analyzed the\ndata. Yuling Mao wrote the manuscript. Hanyan Liu and Rui Chen revised the manuscript. All authors\n\nPage 8/11\nread and approved the nal manuscript.\nAcknowledgements\nThe study was performed under the auspices of the IVF unit of the Third Aliated Hospital of Guangzhou\nMedical University.\nReferences\n1. Gordts S, Koninckx P, Brosens I. Pathogenesis of deep endometriosis. Fertil Steril. 2017;108(6):872–\n85 e1.\n2. Meuleman C, et al. High prevalence of endometriosis in infertile women with normal ovulation and\nnormospermic partners. Fertil Steril. 2009;92(1):68–74.\n3. Senapati S, et al. Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the\nSociety for Assisted Reproductive Technologies Database. Fertil Steril. 2016;106(1):164–71 e1.\n4. Vercellini P, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–\n75.\n5. Du YB, et al. Endocrine and inammatory factors and endometriosis-associated infertility in assisted\nreproduction techniques. Arch Gynecol Obstet. 2013;287(1):123–30.\n. Da Broi MG, et al. Oocyte oxidative DNA damage may be involved in minimal/mild endometriosis-\nrelated infertility. Mol Reprod Dev. 2018;85(2):128–36.\n7. Garrido N, et al. The endometrium versus embryonic quality in endometriosis-related infertility. Hum\nReprod Update. 2002;8(1):95–103.\n. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril.\n2002;77(6):1148–55.\n9. Freis A, et al. Relative Morphokinetics Assessed by Time-Lapse Imaging Are Altered in Embryos From\nPatients With Endometriosis. Reprod Sci. 2018;25(8):1279–85.\n10. Sanchez AM, et al., Is the oocyte quality affected by endometriosis? A review of the literature. Journal\nof Ovarian Research, 2017. 10.\n11. Da Broi MG, et al. Inuence of follicular uid and cumulus cells on oocyte quality: clinical\nimplications. J Assist Reprod Genet. 2018;35(5):735–51.\n12. Miller JE, et al. Implications of immune dysfunction on endometriosis associated infertility.\nOncotarget. 2017;8(4):7138–47.\n13. Taylor RN, Lebovic DI, Mueller MD, Angiogenic factors in endometriosis. Ann N Y Acad Sci, 2002.\n955: p. 89–100; discussion 118, 396–406.\n14. Deguchi M, et al. Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep.\n2001;8(6):1317–9.\n15. Chao J, et al. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body uids, blood cells,\nand tissues in health and disease. J Lab Clin Med. 1996;127(6):612–20.\n\nPage 9/11\n1. Zhu H, et al. Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently\nhealthy African American adolescents. Metabolism. 2013;62(5):642–6.\n17. Miao RQ, et al. Structural elements of kallistatin required for inhibition of angiogenesis. Am J Physiol\nCell Physiol. 2003;284(6):C1604-13.\n1. Shen B, et al. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and\nactivation of Akt-eNOS signaling. Am J Physiol Heart Circ Physiol. 2010;299(5):H1419–27.\n19. Shen B, et al. Salutary effect of kallistatin in salt-induced renal injury, inammation, and brosis via\nantioxidative stress. Hypertension. 2008;51(5):1358–65.\n20. Wang CR, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat\narthritis by inhibiting angiogenesis and inammation. Arthritis Rheum. 2005;52(4):1319–24.\n21. Yin H, et al. Kallistatin inhibits vascular inammation by antagonizing tumor necrosis factor-alpha-\ninduced nuclear factor kappaB activation. Hypertension. 2010;56(2):260–7.\n22. Shiau AL, et al. Inhibition of experimental lung metastasis by systemic lentiviral delivery of\nkallistatin. BMC Cancer. 2010;10:245.\n23. Gao L, et al. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial\ninfarction. Lab Invest. 2008;88(11):1157–66.\n24. Miao RQ, et al. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood.\n2002;100(9):3245–52.\n25. Kollmann Z, et al. Gonadotrophin stimulation in IVF alters the immune cell prole in follicular uid\nand the cytokine concentrations in follicular uid and serum. Hum Reprod. 2017;32(4):820–31.\nTables\nDue to technical limitations, table 1 to 3 is only available as a download in the Supplemental Files\nsection.\nFigures\n\nPage 10/11\nFigure 1\nKS concentrations in women who conceived consequent to the treatment (Pregnancy) and women who\ndid not (Non-pregnancy). (A) KS concentrations in follicular uid of control women in women who\nconceived consequent to the treatment and those who did not. (B) KS concentrations in follicular uid of\nEM patients who conceived consequent to the treatment and those who did not. (C) KS concentrations in\nfollicular uid of all women who conceived consequent to the treatment and women who did not. (*P <\n0.05). (D) ROC curve analysis to assess the predictive powers of clinical pregnancy.\n\nPage 11/11\nSupplementary Files\nThis is a list of supplementary les associated with this preprint. Click to download.\ntable1.jpg\ntable2.jpg\ntable3.jpg","source_license":"CC0","license_restricted":false}